REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 159 filers reported holding REVANCE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $843 | -99.9% | 45,659 | +6.2% | 0.10% | +18.0% |
| Q2 2022 | $594,000 | -54.7% | 42,978 | -36.1% | 0.09% | -49.4% |
| Q1 2022 | $1,311,000 | +80.6% | 67,232 | +174.4% | 0.18% | +114.6% |
| Q2 2021 | $726,000 | +60.6% | 24,498 | -19.9% | 0.08% | -27.4% |
| Q1 2020 | $452,000 | +115.2% | 30,574 | +192.5% | 0.11% | +370.8% |
| Q4 2018 | $210,000 | -48.3% | 10,451 | -29.4% | 0.02% | +20.0% |
| Q2 2018 | $406,000 | – | 14,800 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $48,000,000 | 65.50% |
| Essex Woodlands Management, Inc. | 3,842,047 | $118,335,000 | 25.90% |
| Rhenman & Partners Asset Management AB | 203,181 | $6,258,000 | 0.77% |
| EAM Global Investors LLC | 44,898 | $1,383,000 | 0.72% |
| Fosun International Ltd | 319,313 | $9,835,000 | 0.62% |
| EAM Investors, LLC | 113,096 | $3,483,000 | 0.58% |
| ArrowMark Colorado Holdings LLC | 1,735,699 | $53,460,000 | 0.53% |
| Perceptive Advisors | 618,957 | $19,064,000 | 0.53% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 111,360 | $3,430,000 | 0.45% |
| Schonfeld Strategic Advisors LLC | 83,700 | $2,578,000 | 0.19% |